Registration Dossier

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
Not reported
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Summary information only
Cross-reference
Reason / purpose:
reference to same study

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
1970
Report Date:
1970

Materials and methods

Principles of method if other than guideline:
Not reported
GLP compliance:
not specified
Limit test:
no

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:
Not reported

Test animals

Species:
mouse
Strain:
not specified
Sex:
not specified
Details on test animals and environmental conditions:
Not reported

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
not specified
Details on exposure:
Not reported
Doses:
Not reported
No. of animals per sex per dose:
Not reported
Control animals:
not specified
Details on study design:
Not reported
Statistics:
Not reported

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
ca. 330 other: mm^3
Based on:
not specified
Mortality:
Not reported
Clinical signs:
Symptoms: dyspnea, staggering, convulsions, diarrhea
Body weight:
Not reported
Gross pathology:
individual abdominal adhesions
Other findings:
Not reported

Any other information on results incl. tables

Not applicable

Applicant's summary and conclusion

Conclusions:
Trilon D fluseig was found to have an acute oral LD50 of about 330 mm^3 to mice exposed via intraperitoneal injection.
Executive summary:

Trilon D fluseig was found to have an acute oral LD50 of about 330 mm^3 to mice exposed via intraperitoneal injection.